Eric Rubin

Eric Rubin

Corporate Officer/Principal at MERCK & CO., INC.

Net worth: - $ as of 2023-12-30

65 year
Health Technology
Consumer Services
Miscellaneous

Profile

Eric H.
Rubin
is currently the Senior VP-Global Clinical Oncology at Merck & Co., Inc. He previously worked as the Director-Investigational Therapeutics Division at The Cancer Institute of New Jersey.
Additionally, he served as an Independent Director at Oncorus, Inc. from 2021 to 2023.
He was also a Member of the National Cancer Institute and the American Cancer Society, Inc. Dr. Rubin completed his undergraduate degree at Tulane University (Louisiana) and holds a doctorate from the University of South Florida.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-03-30 0 ( -.--% ) - $ 2023-12-30

Eric Rubin active positions

CompaniesPositionStart
MERCK & CO., INC. Corporate Officer/Principal 2017-12-31
All active positions of Eric Rubin

Former positions of Eric Rubin

CompaniesPositionEnd
ONCORUS, INC. Director/Board Member 2023-07-27
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Eric Rubin's experience

Training of Eric Rubin

Tulane University (Louisiana) Undergraduate Degree
University of South Florida Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Eric Rubin's experience

Connections

100 +

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
MERCK & CO., INC.

Health Technology

ONCORUS, INC.

Health Technology

Private companies3

Miscellaneous

Commercial Services

Health Services

See company connections